Search clinical trials for: Dopamine Agonists

Total 16840 results

The University of Hong Kong

Recruiting

Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia (MainRexult)

Anxiety Depression | Schizophrenia and Related Disorders

Hong Kong
The University of Hong Kong
North District Hospital; Queen Mary Hospital, Hong Kong

Recruiting

Substance Misuse To Psychosis for Stimulants

Schizophrenia and Related Disorders | Stimulant Dependence | Pharmacotherapy | Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis) | Stimulant Abuse

Hong Kong
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics (MAESTRO)

Schizophrenia | Antipsychotics | Long-Acting Injection | LAI | Aripiprazole

Korea, Republic of
Otsuka Pharmaceutical Development & Commercialization...

Completed

Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1) (OSMITTER)

Device Latency

United States
Otsuka Beijing Research Institute

Completed

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder

Autistic Disorder

China
University of Copenhagen
Rigshospitalet, Denmark; UMC Utrecht; Glostrup University Hospital, Copenhagen; Copenhagen Hospital Corporation and other collaborators

Completed

Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS) (PECANS)

Schizophrenia

Denmark
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome

Schizophrenia | Schizoaffective Disorder | Metabolic Syndrome | Bipolar I Disorder

Canada
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Aripiprazole Effects on Alcohol Reactivity and Consumption

Alcohol Dependence

United States
Inje University

Unknown

The New Strategy for Pharmacological Treatment in People With Schizophrenia

Schizophrenia

Korea, Republic of
University of Ulm

Unknown

Dopamine Versus Dobutamine for Treatment of Arterial Hypotension in Term and Preterm Neonates

Arterial Hypotension

Germany
Boehringer Ingelheim

Completed

Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease

Parkinson Disease
University of Miami
Alkermes, Inc.

Recruiting

C-Cog in Early Course Schizophrenia Study

Schizophrenia

United States
Otsuka Beijing Research Institute

Completed

Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia

Schizophrenia

China
University of California, Los Angeles

Completed

Combination Treatment for Augmenting Language in Children With ASD (PIII)

Autism Spectrum Disorder

United States
University of Maryland, Baltimore

Terminated

Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder (PAMS)

Bipolar Disorder

United States
Northwestern University
National Alliance for Research on Schizophrenia and Depression; Pfizer

Completed

Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States
Fundación Marques de Valdecilla
Centro de Investigación Biomédica en Red de Salud Mental; Instituto de Investigación...

Completed

Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up (PAFIP2_3Y)

Psychotic Disorders | Schizophrenia

Spain
Fundación Marques de Valdecilla
Centro de Investigación Biomédica en Red de Salud Mental; Instituto de Investigación...

Completed

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up (PAFIP2_nc1Y)

Psychotic Disorders | Schizophrenia

Spain
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE- EU)

Schizophrenia

Belgium, Bulgaria, Canada
Janssen-Cilag International NV

Completed

A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Psychotic Disorders | Schizophrenia

France, Poland, Germany, Spain, Slovenia, Bulgaria, Romania, Israel, Greece, Sweden, Turkey, Czech Republic, Hungary, Lithuania, Latvia, Portugal, Croatia, Slovakia, Austria, United Kingdom, Estonia, Ireland, Denmark, Saudi Arabia
Otsuka Pharmaceutical Development & Commercialization...

Completed

Aripiprazole in Adolescents With Schizophrenia (APEX 239)

Schizophrenia

United States, Puerto Rico
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

Schizophrenia | Major Depressive Disorder | Mental Disorder | Bipolar I Disorder

United States
VA Office of Research and Development

Withdrawn

VA Aripiprazole vs Esketamine for Treatment Resistant Depression (VAST-D II)

Depressive Disorder, Major

United States
Vanguard Research Group
Otsuka America Pharmaceutical

Completed

Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics (PRELAPSE)

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...

Terminated

A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

Schizophrenia | Major Depressive Disorder | Bipolar 1 Disorder

United States
Seoul National University Hospital
Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder

Major Depressive Disorder

Korea, Republic of
Wei Hao

Terminated

A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychosis

Methamphetamine Dependence

China
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
National Taiwan University Hospital
Yu-Li Hospital; Yu-Li Veterans Hospital

Completed

Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome

Metabolic Syndrome X

Taiwan
Axxonis Pharma AG

Completed

Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)

Restless Legs Syndrome

Germany
Douglas Mental Health University Institute
McMaster University; Jewish General Hospital

Recruiting

Brexpiprazole Treatment for Bipolar I Depression

Bipolar Depression

Canada
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
UCB Pharma

Completed

Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch

Parkinson's Disease

United States, Chile, Mexico, India, Peru
UCB Pharma

Terminated

Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's Disease

Parkinson's Disease

Spain, South Africa, New Zealand, Hungary, United States, Germany, Italy, Australia, Finland, United Kingdom, Poland
UCB Pharma

Completed

Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects

Parkinson's Disease

Korea, Republic of
UCB Pharma

Completed

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease

Early Stage Parkinson's Disease

Poland, United Kingdom, Germany, Spain, Switzerland, Belgium, South Africa, New Zealand, Czech Republic, Austria, Hungary, Australia, Italy, Israel, Sweden, Norway, Croatia, Netherlands, Finland, France
Pfizer

Completed

PF-06669571 In Subjects With Idiopathic Parkinson's Disease

Idiopathic Parkinson's Disease

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Withdrawn

Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety

Major Depressive Disorder (MDD)
Luye Pharma Group Ltd.

Completed

Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease

Parkinson Disease

United States
University Hospital, Grenoble

Unknown

Non Motors Aspects in De Novo Parkinson's Disease (Honeymoon)

Parkinson Disease | Apathy

France
UCB Pharma

Completed

Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine (RECOVER)

Parkinson's Disease

United States, Poland, United Kingdom, Spain, South Africa, Austria, Germany, Hungary, Italy, New Zealand, Australia, Finland
UCB Pharma

Completed

A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's Disease

IDIOPATHIC PARKINSON'S DISEASE

Germany
Peking University Third Hospital

Recruiting

The Practical Effect of Neupro

Parkinson's Disease

China
Luye Pharma Group Ltd.

Completed

Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease (03003MAD)

Parkinson's Disease

United States
UCB Pharma

Completed

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease (SP715)

Parkinson's Disease

United States, Canada
UCB Pharma

Completed

Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)

Restless Legs Syndrome

Germany, Spain, Austria
Ferring Pharmaceuticals

Completed

Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide

Ovarian Hyperstimulation Syndrome

Spain
Tri-Service General Hospital

Completed

Irritability in Children With ADHD and Emotion Dysregulation

ADHD | Irritable Mood

Taiwan
Otsuka Beijing Research Institute

Completed

The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese Subjects

Health

China
Duke University
Otsuka America Pharmaceutical

Terminated

A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSD

Post Traumatic Stress Disorder

United States

Search clinical trials for: Dopamine Agonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations